| __timestamp | Amneal Pharmaceuticals, Inc. | Merck & Co., Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 7180000000 |
| Thursday, January 1, 2015 | 136870000 | 6704000000 |
| Friday, January 1, 2016 | 204747000 | 7194000000 |
| Sunday, January 1, 2017 | 191938000 | 9982000000 |
| Monday, January 1, 2018 | 210451000 | 9752000000 |
| Tuesday, January 1, 2019 | 202287000 | 9872000000 |
| Wednesday, January 1, 2020 | 190585000 | 13397000000 |
| Friday, January 1, 2021 | 209563000 | 12245000000 |
| Saturday, January 1, 2022 | 200046000 | 13548000000 |
| Sunday, January 1, 2023 | 167778000 | 30531000000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, innovation is key to staying ahead. Over the past decade, Merck & Co., Inc. and Amneal Pharmaceuticals, Inc. have shown contrasting approaches to research and development (R&D) investments. From 2014 to 2023, Merck consistently outpaced Amneal, investing nearly 60 times more in R&D on average. In 2023, Merck's R&D expenses soared to a staggering $30.5 billion, marking a 330% increase from 2014. In contrast, Amneal's investment peaked at $210 million in 2018, with a slight decline to $168 million by 2023. This disparity highlights Merck's commitment to innovation, potentially driving breakthroughs in drug development. As the pharmaceutical landscape evolves, these investment trends may shape the future of healthcare, with Merck poised to lead the charge in groundbreaking medical advancements.
R&D Insights: How AbbVie Inc. and Amneal Pharmaceuticals, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Merck & Co., Inc. and Insmed Incorporated
Analyzing R&D Budgets: Merck & Co., Inc. vs Apellis Pharmaceuticals, Inc.
Comparing Innovation Spending: Merck & Co., Inc. and ADMA Biologics, Inc.
R&D Insights: How Merck & Co., Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Dynavax Technologies Corporation
Comparing Innovation Spending: Sarepta Therapeutics, Inc. and Amneal Pharmaceuticals, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs CymaBay Therapeutics, Inc.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Amneal Pharmaceuticals, Inc. or Mesoblast Limited: Who Invests More in Innovation?
Comparing Innovation Spending: Amneal Pharmaceuticals, Inc. and Xencor, Inc.